Literature DB >> 9933647

Characterization of Raf-1 activation in mitosis.

A D Laird1, D K Morrison, D Shalloway.   

Abstract

We have used site-directed mutagenesis to explore the mechanisms underlying Raf-1 activation in mitosis, and we have excluded most previously characterized activating interactions. Our results indicate that the primary locus of activation lies in the carboxyl-half of the molecule, although the extent of activation can be influenced by the amino-proximal region, particularly by the Raf-1 zinc finger. We also found that Raf-1 is hyperphosphorylated in mitosis at multiple sites within residues 283-302 and that these hyperphosphorylations are not required for activation. In addition, neither Mek1 nor Mek2 are stably activated in coordination with Raf-1 in nocodazole-arrested cells. Overall, the data suggest that the mechanism(s) responsible for activating Raf-1 during mitosis, and the subsequent downstream effects, are distinct from those involved in growth factor stimulation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9933647     DOI: 10.1074/jbc.274.7.4430

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Activation of extracellular signal-regulated kinase (ERK) in G2 phase delays mitotic entry through p21CIP1.

Authors:  S Dangi; F M Chen; P Shapiro
Journal:  Cell Prolif       Date:  2006-08       Impact factor: 6.831

2.  Identification of Raf-1 S471 as a novel phosphorylation site critical for Raf-1 and B-Raf kinase activities and for MEK binding.

Authors:  Jun Zhu; Vitaly Balan; Agnieszka Bronisz; Karina Balan; Hengrui Sun; Deborah T Leicht; Zhijun Luo; Jun Qin; Joseph Avruch; Guri Tzivion
Journal:  Mol Biol Cell       Date:  2005-08-10       Impact factor: 4.138

3.  Selective potentiation of paclitaxel (taxol)-induced cell death by mitogen-activated protein kinase kinase inhibition in human cancer cell lines.

Authors:  H M McDaid; S B Horwitz
Journal:  Mol Pharmacol       Date:  2001-08       Impact factor: 4.436

4.  Extracellular signal-regulated kinase 1/2 activity is not required in mammalian cells during late G2 for timely entry into or exit from mitosis.

Authors:  Mio Shinohara; Alexei V Mikhailov; Julio A Aguirre-Ghiso; Conly L Rieder
Journal:  Mol Biol Cell       Date:  2006-10-11       Impact factor: 4.138

5.  Identification of novel in vivo Raf-1 phosphorylation sites mediating positive feedback Raf-1 regulation by extracellular signal-regulated kinase.

Authors:  Vitaly Balan; Deborah T Leicht; Jun Zhu; Karina Balan; Alexander Kaplun; Vinita Singh-Gupta; Jun Qin; Hong Ruan; Michael J Comb; Guri Tzivion
Journal:  Mol Biol Cell       Date:  2006-01-11       Impact factor: 4.138

6.  PLX4032, a selective BRAF(V600E) kinase inhibitor, activates the ERK pathway and enhances cell migration and proliferation of BRAF melanoma cells.

Authors:  Ruth Halaban; Wengeng Zhang; Antonella Bacchiocchi; Elaine Cheng; Fabio Parisi; Stephan Ariyan; Michael Krauthammer; James P McCusker; Yuval Kluger; Mario Sznol
Journal:  Pigment Cell Melanoma Res       Date:  2010-02-10       Impact factor: 4.693

7.  Tyrosine-phosphorylated extracellular signal--regulated kinase associates with the Golgi complex during G2/M phase of the cell cycle: evidence for regulation of Golgi structure.

Authors:  H Cha; P Shapiro
Journal:  J Cell Biol       Date:  2001-06-25       Impact factor: 10.539

8.  Activation of RAF1 (c-RAF) by the Marine Alkaloid Lasonolide A Induces Rapid Premature Chromosome Condensation.

Authors:  Rozenn Jossé; Yong-Wei Zhang; Valentin Giroux; Arun K Ghosh; Ji Luo; Yves Pommier
Journal:  Mar Drugs       Date:  2015-06-05       Impact factor: 5.118

9.  RAF1-activated MEK1 is found on the Golgi apparatus in late prophase and is required for Golgi complex fragmentation in mitosis.

Authors:  Antonino Colanzi; Christine Sutterlin; Vivek Malhotra
Journal:  J Cell Biol       Date:  2003-04-14       Impact factor: 10.539

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.